Biodesix (NASDAQ:BDSX – Get Free Report) is expected to release its Q2 2026 results after the market closes on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the stock. Check Out Our Latest Stock Report on BDSXHedge Funds Weigh In On BiodesixSeveral institutional investors and hedge funds have recently modified their holdings of BDSX. Millennium Management LLC acquired a new position in Biodesix in the 3rd quarter worth $113,000. DRW Securities LLC bought a new position in Biodesix during the 4th quarter worth about $105,000.